TCL Archive Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent January 27, 2012
TCL Archive In Brief: Revlon Foundation Gives $7.5 Million To UCA for Women’s Health Research, Breast Cancer December 16, 1994